Brant Point Investment Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Brant Point Investment Management’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-175,000	Closed	-$3.74M	–	133
2021 Q4	$3.74M	Buy	175,000 +49,598	+40%	+$977K	0.59%	80
2021 Q3	$2.32M	Sell	125,402 -29,598	-19%	-$596K	0.2%	98
2021 Q2	$3.32M	Buy	+155,000	New	+$3.15M	0.31%	91

Other funds holding OCDX

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Brant Point Investment Management's OCDX Position: Q1 2022 in Review

Brant Point Investment Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022, closing a stake of 175,000 shares — an estimated $3.74M sold.

Brant Point Investment Management first reported a position in OCDX in Q2 2021 and held it in 3 quarters. The position peaked at $3.74M in Q4 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

Brant Point Investment Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
Brant Point Investment Management sold 175,000 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $3.74M.
Brant Point Investment Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 3 quarters.
Brant Point Investment Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $3.74M in Q4 2021.
170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.

Based on Brant Point Investment Management's 13F filing for Q1 2022, filed 13 May 2022.